When to Skip IUI and Go Straight to IVF

You are at a transition point. Either your RE just suggested skipping IUI entirely, or you have done one or two IUIs and are wondering whether the next cycle should be IVF instead. You want the actual indications, not "it depends on your situation," and you want to know how much faster the IVF math gets you to a baby compared with three more IUIs. That is what this post is for.

The short version: there is a specific set of clinical situations where IUI is unlikely to deliver and going directly to IVF is the rational first move. Knowing that list is what separates a thoughtful treatment plan from a default ladder that wastes time, money, and emotional resilience. The FORT-T and FAST-T trials are the data the conversation is built on; the indications below are how that data translates to the clinic. (Note for readers who landed here from searches like "when to start progesterone after IUI," I cover that briefly at the end and link you to the right post.)

When IUI is unlikely to deliver: skip straight to IVF

Some indications are essentially absolute. The biology will not let IUI work, and continuing to attempt it is using the wrong tool with full knowledge that it is the wrong tool.

Bilateral tubal blockage or absent fallopian tubes: sperm and egg cannot meet in the tube; this is the textbook indication for IVF. A history of pelvic inflammatory disease, severe pelvic adhesions, prior bilateral salpingectomy for ectopic pregnancy, or hydrosalpinges all fit here. Hydrosalpinx in particular is worth treating before IVF, as the fluid backflow into the uterus reduces implantation; surgical removal or proximal occlusion before IVF transfer is the standard approach.

Severe male-factor infertility: post-wash total motile count consistently under 5 million on repeat samples, severe asthenospermia (very low motility), or severe morphology defects. ICSI through IVF is the tool, because it bypasses the requirement for high motile-sperm count entirely: a single viable sperm per egg is sufficient. The AUA/ASRM guideline on male infertility supports moving to ICSI in this range.⁶ The thresholds are in iui-sperm-count-requirements.

Azoospermia: no sperm in the ejaculate. Surgical retrieval (testicular sperm extraction, microsurgical epididymal sperm aspiration) combined with ICSI is the path forward. IUI is not on the table.

Diminished ovarian reserve with advanced age: AMH under roughly 0.5 to 0.7 ng/mL combined with age 38 and over. IVF prognosis declines with each month at this combination, and the time-to-pregnancy on IUI is too slow for the time available. The FORT-T trial showed accelerated IVF improved time-to-live-birth in 38- to 42-year-olds.²

Stage III or IV endometriosis with anatomical distortion: IVF substantially outperforms IUI here. The mechanical disruption of the pelvis from advanced endometriosis is a barrier that IUI cannot overcome, and the inflammatory environment also affects oocyte quality and implantation.

Genetic indications requiring preimplantation genetic testing: known carrier of a single-gene disorder, balanced chromosomal translocation, or significant family history of a heritable condition. PGT-M (for monogenic disorders) and PGT-SR (for structural rearrangements) require IVF embryos to test before transfer; IUI cannot provide that.

Need for fertility preservation in a time-limited window: cancer diagnosis with planned chemotherapy or radiation, planned surgery affecting the ovaries, or other medical timeline. The few weeks of an IVF stim-and-retrieval cycle are usually accommodatable; an IUI ladder is not.

When IUI is plausible but the math may still favour IVF

A second category. IUI is not biologically impossible, but the expected value is low enough that IVF is often the better first move.

Age 38 and over with unexplained infertility: the FORT-T trial randomised women 38 to 42 to accelerated IVF (two cycles of clomid-IUI then IVF) versus the standard ladder (clomid-IUI, gonadotropin-IUI, then IVF). The accelerated arm reached live birth significantly faster.² This is the data the ASRM 2020 unexplained-infertility guideline references when it supports earlier IVF in this age band.⁴

Repeated failed ovulation induction with confirmed ovulation but no pregnancy across three or more cycles: when you have the ovulation, the partner sample, and the timing right, and the cycles are still negative, the explanation lies outside what IUI can fix. IVF gives you visibility on fertilisation, embryo development, and implantation that IUI never offers. (Setback companion: third-iui-failed-what-now.)

Combined factors: mild male-factor with diminished ovarian reserve and age 36 is not "any one of these is mild." The factors are additive, and the cumulative impact on IUI candidacy is real. A 36-year-old with post-wash TMC of 8 million and AMH of 1.1 is in a different cohort than a 36-year-old with either of those alone.

Recurrent pregnancy loss with infertility: IVF combined with PGT-A (aneuploidy screening) is a consideration. The miscarriage workup takes priority before any further treatment, and the result of that workup may change the recommendation. recurrent-pregnancy-loss-workup is the deeper read.

When IUI is the rational first step

Naming the cases where IUI is the right tool is useful too, because the readers who land here are sometimes second-guessing a reasonable recommendation.

• Unexplained infertility under 35 with normal ovarian reserve. Three cycles of letrozole-IUI is the standard ladder. Cumulative live birth is in the 25 to 35 percent range across three cycles.
• PCOS with confirmed ovulation on letrozole and a normal partner sample. Three to four cycles of letrozole-IUI is reasonable. The PCOS-specific picture is in iui-with-pcos-data.
• Mild male-factor with post-wash total motile count above 10 million: IUI is a reasonable starting protocol.
• Cervical factor or sexual dysfunction preventing conception: a direct indication for IUI; the procedure bypasses the barrier.
• Donor-sperm cycles in someone without female-factor infertility: among the highest IUI numbers in the literature.

The honest cost-time math

I want to put numbers to the "three IUIs vs one IVF" question because it is the question every couple eventually does in a spreadsheet.

For someone under 35 with unexplained infertility:

• Three medicated IUIs: cumulative live birth roughly 25 to 30 percent. Cost roughly $7,500 in the US. Time roughly four to five months.
• One IVF cycle: per-cycle live birth roughly 45 to 50 percent. Cost roughly $20,000 in the US (varies widely with clinic and insurance). Time roughly two months including stim and a fresh or frozen transfer.

For under-35 with no other factors, this is a genuine choice. IUI is reasonable and IVF is not unreasonable. The IUI path is cheaper and slower; the IVF path is more expensive and faster. The right answer is the one that fits your cost ceiling, your time horizon, and your tolerance.

For someone 38 to 40 with unexplained infertility:

• Three medicated IUIs: cumulative live birth roughly 10 to 15 percent. Same cost, same time.
• One IVF cycle: per-cycle live birth roughly 25 to 30 percent. Higher cost (often $22,000 to $25,000 in this age band because more aggressive stim is sometimes needed). Same compressed timeline.

In this band, the per-cycle and cumulative numbers tilt toward IVF, and the time cost of an IUI ladder begins to matter on its own. The FORT-T data formalises this.² The deeper cost-benefit comparison is in iui-cost-benefit-vs-ivf.

What carries over when you transition to IVF

For readers who are making the transition (this post is in the transitioning loop position for that reason), several things from your IUI workup carry forward.

Diagnostic workup: HSG, AMH, antral follicle count, semen analysis, day-3 hormone panel, and TSH are still relevant. IVF does not require redoing them unless something has changed or significant time has passed.

Lifestyle preparation: partner sperm preparation across the 90-day spermatogenesis window, your prenatal vitamin, weight trajectory if relevant, sleep, alcohol moderation: the playbook is the same. IVF does not require a different preconception plan.

Concept-level continuity: trigger and luteal support are conceptually similar. Progesterone support is more intensive in IVF (covered below), but it is the same molecule. Ovulation induction concepts carry over, though the medications are different (gonadotropins instead of oral letrozole).

Diagnostic information from prior cycles: the data points from your IUI cycles inform the IVF protocol. A patient who produced one to two follicles on letrozole at 5 mg with normal estradiol behaves differently in IVF stim than a patient who barely responded. Your RE will use the IUI data to shape the IVF protocol.

What changes

The IVF cycle is a different shape from an IUI cycle.

Egg retrieval: an outpatient procedure under conscious sedation or general anaesthesia, typically 20 to 30 minutes. Recovery is one to three days of low activity, with some cramping and bloating. This is a real recovery day, not a "back to work in an hour" day.

Stimulation injections: daily injections of FSH (Gonal-F, Follistim, Menopur or a combination) for 8 to 14 days, with antagonist injections (Cetrotide, Ganirelix) added partway through to prevent premature ovulation. The stim cycle replaces the five-day course of letrozole or clomid in an IUI cycle. The injections are subcutaneous and self-administered (or partner-administered) after a teaching session at the clinic. Most patients tolerate the injections far better than the anticipation suggests.

Monitoring intensity: bloodwork and transvaginal ultrasound every two to three days during stim, sometimes more often near retrieval. The monitoring cadence is more intense than IUI but compressed into a 10- to 14-day window.

Lab visibility: IVF tells you about fertilisation rate, embryo grade, blastocyst development, and (with PGT) genetic status. IUI tells you only about pregnancy or not. That information has real value when you are trying to understand why prior cycles did not work.

Embryo banking option: IVF can produce multiple embryos in one retrieval cycle, with the option to freeze remaining embryos for future sibling cycles. IUI is one-shot per cycle.

Cost structure: different financial conversation, including potential refund programmes, multi-cycle packages, shared-risk programmes, and pharmacy discount programmes for stim medications. The clinic's financial counsellor is the right person to walk you through this before signing on for IVF.

The conversation to have with your RE

Five questions for the transition consult.

1. Given my specific diagnosis and age, what is my predicted per-cycle live birth on IUI versus IVF?
2. How many IUI cycles would you want me to do before reconsidering, and what would trigger an earlier reconsideration?
3. If we go directly to IVF, what protocol (antagonist, long agonist, mini-IVF) and why that protocol given my history?
4. What does my AMH and antral follicle count suggest about IVF response, and what is the expected egg yield?
5. What does the insurance and financial planning side look like, and are there refund or shared-risk programmes that would change the math?

When to start progesterone after IUI: the quick answer

Some readers find this post searching for "when to start progesterone after IUI" because of how the search engines index this content. The topic of that search belongs in after-your-iui, but the quick answer is here.

Most clinics start luteal-phase progesterone one day after IUI or three days after ovulation (the day of the procedure, conventionally counted as day 14 in a 28-day cycle, with progesterone starting day 15 or 16). Vaginal pessaries or vaginal gel are the most common forms; oral progesterone is less well-absorbed and less commonly used for luteal support. The Cochrane review of luteal-phase support in assisted reproduction supports vaginal progesterone in stimulated cycles.⁷

If the beta is positive, progesterone usually continues through 10 to 12 weeks of pregnancy. If the beta is negative, progesterone is stopped and the period typically arrives within a few days. Forgot a dose? Take it as soon as you remember unless it is nearly time for the next one; do not double up. The schedule is set by your clinic protocol, and you should not start, stop, or change progesterone on your own.

The full post on what to do after an IUI lives at after-your-iui.

What you can do this week

Two practical pieces if you are at the transition decision.

Get your recent labs in one place. Useful items: AMH, antral follicle count from a recent ultrasound, day-3 FSH and estradiol, and your partner's most recent semen analysis with post-wash total motile count if available. Add the HSG result if done, plus the records of any IUI cycles you have run (follicle count at trigger, endometrial thickness, post-wash TMC, day of beta). Bring these to the transition consult; the recommendation made with these in hand will be more specific than one made without.

If you have not yet talked to the clinic's financial counsellor about IVF specifically, do that before committing to the next IUI cycle. IVF coverage and refund programmes meaningfully change the math, and the cost ceiling matters as much as the clinical recommendation. And if your immediate question is when to start progesterone after IUI for this cycle's luteal phase, the after-your-iui post is the dedicated read; the timing is set by your clinic's protocol, not by a generic rule.

What's next

• For the broader decision framework: natural-vs-iui-vs-ivf-decision
• For the cost-benefit math: iui-cost-benefit-vs-ivf
• If three IUIs have failed: third-iui-failed-what-now
• For the male-factor thresholds: iui-sperm-count-requirements
• For what IVF actually looks like: ivf-step-by-step
• For male-factor IVF specifically: ivf-with-icsi-male-factor
• For progesterone after IUI questions: after-your-iui

Sources

1. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the Fast Track and Standard Treatment (FASTT) trial. Fertility and Sterility 2010;94(3):888-899. Link
2. Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertility and Sterility 2014;101(6):1574-1581.e2. Link
3. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility (AMIGOS). New England Journal of Medicine 2015;373(13):1230-1240. Link
4. Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertility and Sterility 2020;113(2):305-322. Link
5. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG156. 2013, updated 2017. Link
6. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline. Fertility and Sterility 2021;115(1):54-61. Link
7. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database of Systematic Reviews 2015;(7):CD009154. Link